InsB9-23 Gene Transfer To Hepatocytes-Based Combined Therapy Abrogates Recurrence Type-1 Diabetes After Islet Transplantation.
Published: 2 February 2022| Version 1 | DOI: 10.17632/gnsk35wyys.1
Contributor:
Description
doi: 10.2337/db19-1249 tabular data related to figure reported (.csv) descriptive document of tabular data (.rtf)
Files
Institutions
Ospedale San Raffaele
Categories
Type 1 Diabetes, Immunotherapy, Islet Transplantation